all report title image

Over the Counter Drugs Market, By Product Type (Cough, Cold, and Flu Products, Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Mineral, and Supplements (VMS), Weight-loss/Dietary Products, Ophthalmic Products, Sleeping Aids, and Other Product Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, and Other Distribution Channels), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Feb 2026
  • Code : CMI1218
  • Pages :152
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical
Ingographics Image

Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a requirement for a prescription (without a prescription) from the healthcare professional, as they are legally allowed to be sold by pharmacists without a prescription. When people follow the directions on the label and as directed by a health care professional, over-the-counter medicines are both safe and effective. Over-the-counter drugs treat a variety of illnesses and their symptoms and help cure some diseases simply and without the cost of seeing a doctor.

Market Dynamics

Increase in disease burden, increase in demand for OTC drugs, rising trend of self-medication, the outbreak of COVID-19, and inclination of pharma companies toward OTC drugs from RX drugs are major factors expected to drive growth of the global during the counter drugs market over the forecast period.

In June 2022, Glenmark Pharmaceuticals Ltd. acquired the approved generic versions of certain over-the-counter drugs from Wockhardt Ltd. in the U.S. The acquisition includes the approved abbreviated new drug applications (ANDAs) for famotidine tablets, 10 mg and 20 mg used to treat and prevent ulcers in the stomach and intestine, the company said in a statement.

In July 2020, Novartis announced a new initiative to help patients in low-income and lower-middle-income countries access affordable medicines to treat the major symptoms of COVID-19, a critical need in the absence of a vaccine or curative treatment. The Novartis COVID-19 portfolio includes 15 generic and OTC medicines from Sandoz division addresses urgent unmet needs of low- and lower-middle-income countries to treat patients with COVID-19 symptoms.

Key features of the study

  • This report provides in-depth analysis of the global over the counter drugs market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global over the counter drugs market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Pfizer Inc., Perrigo Company PLC, GlaxoSmithKline PLC, Mylan NV, Bayer AG, Reckitt Benckiser Group PLC, Johnson and Johnson, Sanofi, and Takeda Pharmaceutical Company Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global over the counter drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global over the counter drugs market.

Market Segmentation

  • By Product Type
    • Cough, Cold, and Flu Products
    • Analgesics
    • Dermatology Products
    • Gastrointestinal Products
    • Vitamins
    • Mineral and Supplements (VMS)
    • Weight-loss/Dietary Products
    • Ophthalmic Products
    • Sleeping Aids
    • Other Product Types
  • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacy
    • Other Distribution Channels
  • By Regional Insights:
    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC Countries
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • North Africa
      • Central Africa
  • Key Players Insights
    • Pfizer Inc.
    • Perrigo Company PLC
    • GlaxoSmithKline PLC
    • Mylan NV
    • Bayer AG
    • Reckitt Benckiser Group PLC
    • Johnson and Johnson
    • Sanofi
    • Takeda Pharmaceutical Company Ltd.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • PEST Analysis
      • PORTER’s Five Forces Analysis
      • Market Opportunities
      • Regulatory Scenario
      • Key Developments
      • Industry Trend
  4. Global Over the Counter Drugs Market, By Product Type, 2026-2033, (USD Bn)
    • Introduction
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 - 2033
      • Segment Trends
    • Cough, Cold, and Flu Products
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 – 2033
      • Segment Trends
    • Analgesics
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 – 2033
      • Segment Trends
    • Dermatology Products
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 - 2033
      • Segment Trends
    • Gastrointestinal Products
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 - 2033
      • Segment Trends
    • Vitamins
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 - 2033
      • Segment Trends
    • Mineral and Supplements (VMS)
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 - 2033
      • Segment Trends
    • Weight-loss/Dietary Products
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 - 2033
      • Segment Trends
    • Ophthalmic Products
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 - 2033
      • Segment Trends
    • Sleeping Aids
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 - 2033
      • Segment Trends
    • Other Product Types
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 - 2033
      • Segment Trends
  5. Global Over the Counter Drugs Market, By Distribution Channel, 2026-2033, (USD Bn)
    • Introduction
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 - 2033
      • Segment Trends
    • Hospital Pharmacies
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 – 2033
      • Segment Trends
    • Retail Pharmacies
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 – 2033
      • Segment Trends
    • Online Pharmacy
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 – 2033
      • Segment Trends
    • Other Distribution Channels
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 – 2033
      • Segment Trends
  6. Global Over the Counter Drugs Market, By Region, 2026-2033, (USD Bn)
    • Introduction
      • Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, For Region, 2021 - 2033
    • North America
      • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
      • Y-o-Y Growth Analysis, For Country, 2021 - 2033
      • Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
      • Y-o-Y Growth Analysis, For Country, 2021 - 2033
      • Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
      • Y-o-Y Growth Analysis, For Country, 2021 - 2033
      • Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
      • Y-o-Y Growth Analysis, For Country, 2021 - 2033
      • Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
      • Y-o-Y Growth Analysis, For Country, 2021 - 2033
      • Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
      • Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
      • Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
        • South Africa
        • North Africa
        • Central Africa
  7. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis (3x3 Matrix)
    • Company Profiles
      • Pfizer Inc.
        • Company Overview
        • Product Type Portfolio
        • Recent Developments/Updates
      • Perrigo Company PLC
        • Company Overview
        • Product Type Portfolio
        • Recent Developments/Updates
      • GlaxoSmithKline PLC
        • Company Overview
        • Product Type Portfolio
        • Recent Developments/Updates
      • Mylan NV
        • Company Overview
        • Product Type Portfolio
        • Recent Developments/Updates
      • Bayer AG
        • Company Overview
        • Product Type Portfolio
        • Recent Developments/Updates
      • Reckitt Benckiser Group PLC
        • Company Overview
        • Product Type Portfolio
        • Recent Developments/Updates
      • Johnson and Johnson
        • Company Overview
        • Product Type Portfolio
        • Recent Developments/Updates
      • Sanofi
        • Company Overview
        • Product Type Portfolio
        • Recent Developments/Updates
      • Takeda Pharmaceutical Company Ltd.
        • Company Overview
        • Product Type Portfolio
        • Recent Developments/Updates
  8. Analyst Recommendation
    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  9. Section
    • References
    • Research Methodology
    • About Us and Sales Contact
  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.